Epsilon Aminocaproic Acid and the Control of Post-Prostatectomy Bleeding: A Prospective Double-Blind Study
- 1 June 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 131 (6) , 1093-1095
- https://doi.org/10.1016/s0022-5347(17)50827-7
Abstract
Patients (61) undergoing transurethral resection of the prostate were randomized in a double-blind parallel fashion to recieve epsilon aminocaproic acid or an equivalent volume of placebo solution immediately after the operation. All blood loss during the first 72 h postoperatively was monitored. Four patients were nonevaluable. The use of epsilon aminocaproic acid caused no significant complication or side effect. There was no significant difference in regard to blood loss, hospital stay or days on catheter drainage between the 2 groups. The routine use of epsilon aminocaproic acid after transurethral resection of the prostate is not warranted.This publication has 9 references indexed in Scilit:
- Basis of antifibrinolytic therapyJournal of Clinical Pathology, 1980
- Transurethral Prostatectomy: Computerized Analysis of 2,223 Consecutive CasesJournal of Urology, 1974
- The effect of the fibrinolytic inhibitor epsilonaminocaproic acid on the incidence of deep-vein thrombosis after prostatectomyBritish Journal of Surgery, 1972
- Prostatectomy and Deep-Vein ThrombosisBritish Journal of Surgery, 1972
- AMINOCAPROIC ACID IN THE CONTROL OF HÆMORRHAGE AFTER PROSTATECTOMY: Safety of Aminocaproic Acid—a Controlled TrialThe Lancet, 1966
- The Use of Epsilon Aminocaproic Acid, a Potent Inhibitor of Fibrinolytic Activity, in the Management of Postoperative HematuriaJournal of Urology, 1961
- The Fibrinolytic Activity of Human TissuesBritish Journal of Haematology, 1957
- THE FIBRINOLYTIC ACTIVITY OF URINE1951